Indian Prime Minister Narendra Modi and Greek Prime Minister Kyriakos Mitsotakis are committed to enhancing cooperation across multiple sectors, including technology, pharmaceuticals, skill development, space, and innovation.
The Indian Pharmacopoeia Commission (IPC) has released the Draft Pharmacovigilance Guidance Document for Pharmaceutical Products in its latest version, Version 2.0.
The drug regulatory department in the state of Jharkhand is planning to conduct a workshop to raise awareness on maintaining the quality of medicines for the drug manufacturers and distributors who supply medicines for the state's needs.
Aptar Digital Health, which offers digital health solutions globally, has recently acquired Healint, a digital health company based in Singapore. According to Aptar Digital Health, the acquisition of Healint is in line with their plan to expand...
A scientific team funded by the National Institutes of Health (NIH) has found new ways to improve the accuracy of a genetic testing method called a polygenic risk score.
WuXi Advanced Therapies (WuXi ATU), a subsidiary of WuXi AppTec, announced that its Philadelphia site has received FDA approval to begin analytical testing and manufacturing of Amtagvi for Iovance.
Researchers found more than 275 million previously unreported genetic variants in data shared by nearly 250,000 National Institutes of Health's Global Research Program participants.
Indian drug firms are exploring opportunities in the Kingdom of Saudi Arabia (KSA), an $8.9 billion pharmaceutical (pharma) market, as the latter is keen to procure more pharmaceutical products from India.
The pharma landscape has significantly shifted towards collaboration and partnership between global big pharma and Indian pharma firms in recent years to drive innovation and expand market reach.
The primary endpoint in the phase 3 registrational study (RESTORE-1) of IBI311, a recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody, in Chinese subjects with thyroid eye disease (TED) has been achieved, according to...